The delivery of therapeutics into cells is important for biomedical applications ranging from gene therapy to drug delivery. Since the commercial introduction of Doxil ® , particle-based drug carriers have been used to improve therapeutic outcomes.
[1] Carriers are useful for transporting drugs to cells and reducing the nonspecific toxicity of the drug, while cocktails of therapeutics are receiving intense study for enhancing the specific desired toxicity. [2] The combination of a non-toxic facilitating molecule with specific therapeutics has proven to be especially useful for promoting enhanced cellular responses. [3] Cell penetrating peptides (CPPs) are a useful class of facilitator molecules that have found application in imaging, and gene and drug delivery. [4] A particularly interesting CPP is the non-toxic arginine-rich trans-activating transcriptional activator (Tat) and the corresponding engineered derivatives. These CPPs have been used to enhance cellular uptake, endosomal escape and/or nuclear targeting to facilitate improved therapeutic responses. [3a,5] Although co-delivery of a CPP and a drug is widely used in research, no reports have shown tunable cytotoxicity by varying the ratio of CPP to drug, which would allow enhanced control over dosage. The lack of studies into peptide-gated cytotoxicity is most likely limited because CPPs are often conjugated directly to the carrier or cargo, thereby making it difficult to selectively vary the concentration of one or the other. [3b,4b,6] Herein, we report for the first time the tunable co-delivery of an engineered Tat-based CPP and a chemotherapeutic drug for enhanced and controllable cytotoxicity using an engineered polymer carrier assembled in one-step.
The cytotoxicity was selectively tuned up to a factor of 30 simply by varying the amount of CPP loaded into the nanoparticles (NPs). Monodisperse, multi-cargo loaded NPs were assembled through a modular one-step process by mixing two simple polymer molecules; a polyethylene glycol-doxorubicin conjugate (PEG-Dox), and a poly(2-diisopropylaminoethyl methacrylate) (PDPA) homopolymer, with a custom designed arginine (R) and histidine (H) containing CPP; NH 2 -HHHH-RRRR-COOH (H4R4).
H4R4 was designed to combine the benefits of arginine/Tat-based CPPs with the endosomal escape and pH-dependent properties of histidine. [7] With a pKa of ~6.5, [8] poly-histidine has similar material characteristics to PDPA; that is, both shift from hydrophobic to hydrophilic when the pH is below ~6.5.
[9] Therefore, H4R4 selfassembled with PDPA and PEG-Dox to form monodisperse NPs. At physiological pH, PDPA forms a hydrophobic core, immobilizing H4R4 and Dox into place while allowing PEG to extend out from the core and to form a hydrophilic corona.
Following entrance into the acidic endosomal compartments, [10] PDPA and H4 become protonated and destabilize the NPs due to electrostatic repulsion, thereby releasing Dox (Scheme 1). PDPA was chosen as a core stabilizer because of its pHresponsive nature. Our previous work has shown that pH-sensitive PDPA-based systems can be internalized and disassembled in cells. [11] Furthermore, PDPA eliminates the leakage and concentration-dependent stability issues of some other nanostructures (e.g., non-cross-linked micelles, polymersomes). [12] The reported NPs offer three other major advantages over similar systems. First, while most NP-and micelle-based systems have reduced toxicity in comparison to free drug, H4R4
allowed our system to have a significantly higher toxicity than free drug. Second, the fact that the peptide and anti-cancer drug are unconjugated allows for a high degree of control over peptide loading and enhanced chemotherapeutic efficacy. Third, the therapeutic cargo was prepared through a one-step reaction that only requires simple conjugation chemistry rather than complex polymer synthesis. This strategy could be easily applied to a wide range of biomolecules. This simple and modular assembly technique will allow different hydrophobic therapeutic molecules to be easily incorporated, making it attractive for diverse biomedical applications. The prepared NPs encompass pH-induced loading and release of cargo, and achieve simultaneous and tunable co-delivery of peptides and anticancer drugs. NPs with a size of 100 nm are advantageous for drug delivery because they are capable of utilizing the enhanced permeability and retention (EPR) effect. [13] Furthermore, Fourier transform infrared spectroscopy (FTIR) and matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) spectrometry (Supporting Information, Figures S2 and S3) were used to confirm the incorporation of PEG-Dox and H4R4 in the NPs. From FTIR, all characteristic peaks that belong to PDPA were observed: C=O bonding at 1730 cm -1 , C-H vibration peaks at 2948, 2920, and 2890 cm -1 and the C-N stretching vibration at 1025 cm -1 were assigned to the 2-diisopropyl amino group. The amide I peak at 1660 cm -1 in the H4R4 was observed only in the H4R4-PDPA NPs, indicating successful incorporation of the peptide. For PDPA-NPs and H4R4 (3.0 wt%)-PDPA-NPs, the PEG-Dox encapsulation efficiency was calculated to be 70% and 40% respectively, while the loading efficiency was calculated to be 56% and 32% respectively (see Experimental Section). To demonstrate the pH-induced release of cargo, the Dox release kinetics from the NPs was investigated at both the extracellular pH of 7.4 and the endosomal pH of 5.5. [10] At pH 7.4, less than 10% of Dox was released within 36 h, suggesting that the NPs are largely stable at extracellular pH; in contrast, at pH 5.5, over 90% of the assay (Figure 3 ). PDPA NPs were less cytotoxic than free Dox, which is common in micelle and NP systems. [14] Interestingly, the loading of H4R4 (3.0 wt%) significantly augmented the cytotoxic effect of the NPs. The free H4R4 peptide, as well as PDPA, had no effect on cell viability, demonstrating that the cytotoxicity of the NPs is due to Dox (Supporting Information, Figure S4b ). The mixed solution of H4R4 and PEGDox did not lead to enhanced cytotoxicity (Supporting Information, Figure S4a In conclusion, multifunctional NPs were synthesized in one-step by mixing several simple building blocks. The resultant NPs possessed a pH trigger to simultaneously lock/release anticancer drugs and peptides. We have demonstrated tunable cytotoxicity through non-toxic peptide-facilitated gating. This simple and versatile assembly technique will allow diverse hydrophobic drugs/diagnostic molecules to be easily incorporated, making it attractive for a wide range of biomedical applications.
Experimental Section
Materials: 2-diisopropylaminoethyl methacrylate (DPA) was purchased from Polysciences, Inc. and passed over basic alumina ( Conjugation of Dox-PEG: PEG-NHS (10 mg, 5 mmol), Dox (4.35 mg, 7.5 mmol), and triethylamine (1.25 µL, 9 mmol) was dissolved in methanol (10 mL). The resulting solution was stirred at 23 °C for 2 h and then dialyzed against deionized water more than ten times (MW cutoff = 2K, Spectra/Por 6) and freeze dried.
Preparation of PDPA NPs: 2 mg Dox-PEG and 1 mg PDPA was dissolved in 0.3 mL ethanol. For the H4R4-loaded particles, 0.2 mg (0.7 wt%), 0.1 mg (3 wt%) and 0.5 mg (14 wt%) H4R4 was added in the above mentioned solution mixture. This solution was then added drop-by-drop to 3 mL PBS while vigorous stirring. The organic solvent was evaporated while being stirred for 48 h. The remaining solution was filtered through a 0.45 μm pore size filter to remove any polymer aggregates and then dialyzed against PBS more than ten times to remove free polymers and peptides in the solution (MW cutoff = 10 000, Thermo Scientific).
Characterization of PDPA NPs:
The size of PDPA NPs was determined using a Malvern Zeta Sizer NanoZS (Malvern Instruments, UK) measuring at a fixed scattering angle of 173°. The morphology of the particles was analyzed using transmission electron microscopy (TEM) and atomic force microscopy (AFM). TEM images were taken by Philips CM120 BioTWIN TEM with an operation voltage of 120 kV. Samples of NPs were air-dried on a carbon-coated Formvar film mounted on 300 mesh copper grids (ProSciTech, Australia). Negative staining was achieved by adding a drop of phosphotungstic acid (1 mg/mL) in deionized water. For AFM measurements, particle solutions air-dried on silica wafers were mounted on a NanoWizard II AFM (JPK Instruments, Berlin, Germany) in intermittent contact mode with MikroMasch silicon cantilevers (NSC/CSC). Fourier transform infrared (FTIR) spectra were recorded on a Varian 7000 FTIR spectrometer with a Specac MKII Golden Gate single-reflectance diamond ATR attachment with KRS-5 optics and a heated top plate maintained at 30 °C. Polymer particle solutions were dropped and dried onto the diamond ATR crystal, and spectra were collected in the absorbance mode from 4000 to 400 cm -1 at a resolution of 2 cm -1 . The PEG-Dox encapsulation efficiency was calculated by using the weight of PEG-Dox in the filtered NPs and the total weight of PEG-Dox added, while the loading efficiency was calculated using the weight of PEG-Dox in the filtered NPs and the weight of the freeze-dried filtered NPs.
The weight of PEG-Dox loaded in the filtered NPs was determined from a calibration curve by disassembling the NPs and diluting the solution appropriately.
In vitro release profile: 1 mL of the PDPA NP or H4R4-PDPA NP dispersion was 
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